Observational study of patients under anticoagulation therapy
- Conditions
- COVID-19 CoagulopathyD69.59
- Registration Number
- DRKS00028689
- Lead Sponsor
- niversitätsklinikum Carl Gustav CarusKlinik und Poliklinik für Anästhesie und Intensivtherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
Intravenous anticoagulation therapy with argatroban.
Exclusion Criteria
None
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation between laboratory parameters and plasma values analyzed using pearson or spearman correlation.
- Secondary Outcome Measures
Name Time Method